Particularly intriguing is the evidence suggesting that IGF2 expression can promote cancer immunoevasion, which is therefore another response elicited by IGF2, in addition to tumor cell motility, invasion, stem phenotype, and angiogenesis, thereby indicating that IGF2 is a pleiotropic promoter of metastatic spread in cancer. This evidence concerns the gene IGF2 and cancer.